Inventor · name-matched record
SCHEIBLER LUKAS
0 granted patents·2 pending applications·0 citations·filing 2025–2025
Technology areasA61K
Files withCELLA THERAPEUTICS LLC2
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
2 records- 0184US2026048097A1Drug delivery systems comprising an intraocular pressure lowering agent, a neurotrophic agent, a c-type natriuretic peptide, a natriuretic peptide receptor-b, an apoptosis signaling fragment inhibitor or a fas-ligand inhibitor for treating glaucoma or ocular hypertensionCELLA THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 0275US2026041777A1Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (fas) or fas ligand (fasl) inhibitor, a tumor necrosis factor-alpha (tnf-alpha) or tnf receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitorCELLA THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SCHEIBLER LUKAS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →